High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis Research Letter


Authors: Zhai, B.; Ola, M.; Rolling, T.; Tosini, N. L.; Joshowitz, S.; Littmann, E. R.; Amoretti, L. A.; Fontana, E.; Wright, R. J.; Miranda, E.; Veelken, C. A.; Morjaria, S. M.; Peled, J. U.; van den Brink, M. R. M.; Babady, N. E.; Butler, G.; Taur, Y.; Hohl, T. M.
Title: High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis
Abstract: The intestinal microbiota is a complex community of bacteria, archaea, viruses, protists and fungi1,2. Although the composition of bacterial constituents has been linked to immune homeostasis and infectious susceptibility3–7, the role of non-bacterial constituents and cross-kingdom microbial interactions in these processes is poorly understood2,8. Fungi represent a major cause of infectious morbidity and mortality in immunocompromised individuals, although the relationship of intestinal fungi (that is, the mycobiota) with fungal bloodstream infections remains undefined9. We integrated an optimized bioinformatics pipeline with high-resolution mycobiota sequencing and comparative genomic analyses of fecal and blood specimens from recipients of allogeneic hematopoietic cell transplant. Patients with Candida bloodstream infection experienced a prior marked intestinal expansion of pathogenic Candida species; this expansion consisted of a complex dynamic between multiple species and subspecies with a stochastic translocation pattern into the bloodstream. The intestinal expansion of pathogenic Candida spp. was associated with a substantial loss in bacterial burden and diversity, particularly in the anaerobes. Thus, simultaneous analysis of intestinal fungi and bacteria identifies dysbiosis states across kingdoms that may promote fungal translocation and facilitate invasive disease. These findings support microbiota-driven approaches to identify patients at risk of fungal bloodstream infections for pre-emptive therapeutic intervention. © 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.
Keywords: adult; clinical article; controlled study; single nucleotide polymorphism; case control study; nonhuman; letter; retrospective study; saccharomyces cerevisiae; bloodstream infection; infection prevention; intestine flora; bioinformatics; micafungin; fungal dna; phylogenetic tree; candidemia; dna 16s; microbial diversity; bacterial load; antifungal resistance; candida parapsilosis; invasive candidiasis; human; priority journal; dna 18s; candida metapsilosis; candida orthopsilosis; species translocation
Journal Title: Nature Medicine
Volume: 26
Issue: 1
ISSN: 1078-8956
Publisher: Nature Publishing Group  
Date Published: 2020-01-01
Start Page: 59
End Page: 64
Language: English
DOI: 10.1038/s41591-019-0709-7
PUBMED: 31907459
PROVIDER: scopus
PMCID: PMC7005909
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ngolela Esther Babady
    171 Babady
  2. Tobias Martin Hohl
    105 Hohl
  3. Ying Taur
    147 Taur
  4. Edwin Miranda
    10 Miranda
  5. Jonathan U Peled
    154 Peled
  6. Bing   Zhai
    16 Zhai
  7. Emily Fontana
    31 Fontana
  8. Roberta Justine Wright
    15 Wright
  9. Nicholas Lepard Tosini
    6 Tosini
  10. Thierry Rolling
    12 Rolling